Hap Trading, LLC Provention Bio, Inc. Call Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	SELL	$6.7 - $24.21 $207,030 - $748,089	-30,900 Reduced 73.57%	11,100 $152,000
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $17,176 - $40,166	3,800 Added 9.95%	42,000 $97,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $131,026 - $214,684	38,200 New	38,200 $31,000
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $97,266 - $128,586	17,400 Added 115.23%	32,500 $8,000
Q3 2021 Nov 10, 2021	BUY	$5.66 - $8.33 $28,300 - $41,650	5,000 Added 49.5%	15,100 $8,000
Q2 2021 Aug 11, 2021	SELL	$6.71 - $11.04 $50,996 - $83,904	-7,600 Reduced 42.94%	10,100 $11,000
Q1 2021 May 14, 2021	BUY	$10.12 - $19.45 $179,124 - $344,265	17,700 New	17,700 $23,000
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $123,794 - $198,870	-10,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$10.34 - $15.2 $110,638 - $162,640	-10,700 Reduced 50.47%	10,500 $35,000
Q2 2020 Aug 10, 2020	BUY	$7.81 - $17.0 $165,572 - $360,400	21,200 New	21,200 $8,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.